Feifei Yang

机构：Xi'an University of Science and Technology, Chinese Academy of Medical Sciences & Peking Union Medical College, Fudan University, University of Jinan, Construction Development (Qatar), Huashan Hospital, First Affiliated Hospital Zhejiang University, China Agricultural University, Chengdu University of Traditional Chinese Medicine, East China Normal University, Nanjing Medical University · ORCID：0000-0001-9362-7635

发表论文 119 篇 · 总被引 2333 次 · h-index 27

代表论文

• A Self‐Catalytic NO/O 2 Gas‐Releasing Nanozyme for Radiotherapy Sensitization through Vascular Normalization and Hypoxia Relief (2024 · Advanced Materials · 被引 41)
• First total synthesis, antitumor evaluation and target identification of mornaphthoate E: A new tubulin inhibitor template acting on PI3K/Akt signaling pathway (2024 · Acta Pharmaceutica Sinica B · 被引 15)
• Discovery of a novel hybrid coumarin-hydroxamate conjugate targeting the HDAC1-Sp1-FOSL2 signaling axis for breast cancer therapy (2024 · Cell Communication and Signaling · 被引 13)
• Discovery of Novel Imidazo[1,2- a ]pyridine-Based HDAC6 Inhibitors as an Anticarcinogen with a Cardioprotective Effect (2024 · Journal of Medicinal Chemistry · 被引 9)
• The long coiled-coil protein NECC2 regulates oxLDL-induced endothelial oxidative damage and exacerbates atherosclerosis development in apolipoprotein E −/− mice (2024 · Free Radical Biology and Medicine · 被引 9)
• Deep-learning features based on F18 fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) to predict preoperative colorectal cancer lymph node metastasis (2024 · Clinical Radiology · 被引 8)